Adverse events after drug infusion
. | Treatment . | . | . | ||
---|---|---|---|---|---|
. | Group 1 . | Group 2 . | . | ||
Symptoms . | DDAVP; n . | Eptifibatide and l-aspirin; n . | Eptifibatide, l-aspirin, and DDAVP;n . | ||
Headache | 4 | 2 | 4 | ||
Hypotension* | 3 (systemic) | 3 (systemic) | 5 (systemic) | ||
8 (diastolic) | 5 (diastolic) | 7 (diastolic) | |||
Facial flush | 1 | 0 | 2 | ||
Nausea | 1 | 0 | 0 | ||
Thrombocytopenia† | 0 | 0 | 0 |
. | Treatment . | . | . | ||
---|---|---|---|---|---|
. | Group 1 . | Group 2 . | . | ||
Symptoms . | DDAVP; n . | Eptifibatide and l-aspirin; n . | Eptifibatide, l-aspirin, and DDAVP;n . | ||
Headache | 4 | 2 | 4 | ||
Hypotension* | 3 (systemic) | 3 (systemic) | 5 (systemic) | ||
8 (diastolic) | 5 (diastolic) | 7 (diastolic) | |||
Facial flush | 1 | 0 | 2 | ||
Nausea | 1 | 0 | 0 | ||
Thrombocytopenia† | 0 | 0 | 0 |